Huw M. Nash - Chief Business Officer at Stoke Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
STOK on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Huw M. Nash - trading volume in the past year for Stoke Therapeutics, Inc.

Holdings reported by Huw M. Nash for Stoke Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 40,000 $631 K $15.78 Mar 27, 2024 Direct Common Stock
Common Stock 0 $0 $13.90 Jul 2, 2024 Direct
Stock Option (Right to Buy) 46,000 May 20, 2024 Direct Common Stock

Transactions reported by Huw M. Nash for Stoke Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership